From owner-7tms_r@net.bio.net Tue Apr 06 23:00:00 1999
Path: biosci!biosci!not-for-mail
From: edvard@fagmed.uit.no (Oyvind Edvardsen)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Mutant database tinyGRAP release 7 is available
Date: 7 Apr 1999 08:24:13 -0700
Organization: Univ. of Tromso, IMB
Lines: 86
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <7eftat$ppg@net.bio.net>
Reply-To: edvard@fagmed.uit.no
NNTP-Posting-Host: net.bio.net


We are pleased to announce the availability of release 7 of tinyGRAP.

tinyGRAP release 7 is a collaborative release between
* Leiden Amsterdam Center for Drug Research/LACDR (M. Beukers)
* Royal Danish School of Pharmacy/DFH (K. Kristiansen)
* University of Tromso (O. Edvardsen)
* BIOcomputing group at EMBL, Heidelberg (G. Vriend et al.).

Changes:
* Added ~2600 mutants.
* Insertion mutants have been added.
* Receptor peptides have been added.
* Annotation on experimental conditions and qualitative effects
  of mutagenesis is available for ~50% of the mutants (i.e.
  all mutants added in this release and the previous release).
* Around 280 duplicates were merged.
* According to information in Swiss-Prot 37 the following
  information has been checked & updated:
  -all secondary structure assignments
  -species information
  -amino acids and their positions (numbers)
  -links into OMIM
* Receptor names have been updated.
* Annotation on receptor splice variants has been added.
* All bibliographic information has been checked and updated.
* Database indices have been made more reliable to ensure correct answers.
* All software has been rewritten. Simpler methods for linking into tinyG=
RAP
  have been developed.
* A dedicated tinyGRAP server has been installed.

o   Margot Beukers at LACDR and Kurt Kristiansen at DFH have done the
    tedious job of entering data.
    Margot has also been active in the development of all parts of the
    database system.=20
o   Gert Vriend et al. at BIOcomputing, EMBL, Heidelberg has contributed =
by
    arranging yet another fruitful GPCR workshop (Heidelberg, March this
    year), by his interest in GPCRs and by taking part in and creating
    interesting discussions.
o   Oyvind Edvardsen at University of Tromso has created
    programs to check input data and has done all the other
    software and database maintainance stuff.

We would like to thank all the participants at the GPCRDB workshop in
Heidelberg, March this year, for all comments and suggestions.

In order to continue to provide computerized mutant data we
need YOUR help. If you can't locate YOUR paper(s) in tinyGRAP, at least
send us a notification. Even better if YOU would send reprint(s). The=20
postal address is given below.

User feedback is always welcome.

Access tinyGRAP from the GRAP homepage:
http://www-grap.fagmed.uit.no/GRAP/homepage.html
Above is the one and only URL that can be guaranteed to be persistent.
Alternatively, you can access tinyGRAP directly on the
dedicated server http://tinyGRAP.uit.no/.

Other access method:
Mutant data can be accessed from the services of the GPCRDB at
http://www.gpcr.org/7tm/.



On behalf of the tinyGRAP release 7 team,
=D8yvind Edvardsen


- --=20
- -o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-=
o-o-
___                    _                    =20
| /|              _|  |_  _|     __   _  _|  _  _
|/_| \/ \/ | |\| |_|  |_ |_| \/ |_|_ |  |_| _\ |_' |\|
     /
_________________________________________________________________________=
____
Dept. of Pharmacology             |  TelePhone: +47 77 64 66 33
Institute of Pharmacy             |  TeleFax:   +47 77 64 66 45
University of Troms=F8              |  Email: edvard@fagmed.uit.no
N-9037 TROMS=D8, NORWAY             |  URL: http://capsg.farmasi.uit.no/
- -------------------------------------------------------------------------=
- -----

From owner-7tms_r@net.bio.net Tue Apr 06 23:00:00 1999
Path: biosci!biosci!not-for-mail
From: "QSAR2000" <qsar2000@pharm.uni-duesseldorf.de>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: QSAR2000 congress
Date: 7 Apr 1999 08:23:48 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 72
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <7efta4$pn7@net.bio.net>
NNTP-Posting-Host: net.bio.net


- --PART-BOUNDARY=.19904062003.ZM11134.pharm.uni-duesseldorf.de
Content-Description: Text
Content-Type: text/plain ; charset=iso-8859-1
Content-Transfer-Encoding: quoted-printable
X-Zm-Decoding-Hint: mimencode -q -u 

#########################################################################=
######

   13th European Symposium on Quantitative Structure-Activity Relationshi=
ps
                       27 August - 1 September 2000
                    Rational Approaches to Drug Design

#########################################################################=
######

                        First Announcement and Invitation

The Institute for Pharmaceutical Chemistry at the Heinrich-Heine-Universi=
ty
Duesseldorf is proud to announce the 13th European Symposium on Quantitat=
ive
Structure-Activity Relationships to be held in Duesseldorf, 27 August - 1=

September 2000. The congress will be organized by the local organizing
committee under the patronage of the Ministry for Education and Science o=
f the
state of Nordrhein-Westfalen.

The city of Duesseldorf is located in the North-West of Germany, at short=

distance from K=F6ln, Bonn and the Ruhrgebiet.

The scientific programme will include an opening lecture by Camille G. We=
rmuth
on "The Impact of QSAR and CAMD Methods on Drug Discovery", eight plenary=

lectures by well known scientists on the most actual topics in todays dru=
g
design research, as well as 24 selected communications and a poster sessi=
on.


For further information please address the conference home page

    http://pharm.uni-duesseldorf.de/qsar2000

Those interested in attending the Symposium and presenting a poster or an=
 oral
communication are invited to return the Preliminary Registration Form (lo=
cated
on the conference home page). Provisional application does not imply any
obligation, but will greatly assist the organizing committee in its prepa=
ratory
work and ensure receipt of the second annoucement which will be distribut=
ed end
of 1999.


Hoping to meet you 2000 in Duesseldorf
H.-D. Hoeltje

Institute for Pharmaceutical Chemistry
Heinrich-Heine-University Duesseldorf
Universitaetsstr. 1
D-40225 Duesseldorf, Germany
Tel: +49 211 811 3835 - Fax +49 211 811 3847
e-mail: qsar2000@pharm.uni-duesseldorf.de

- --PART-BOUNDARY=.19904062003.ZM11134.pharm.uni-duesseldorf.de--

From owner-7tms_r@net.bio.net Tue Apr 06 23:00:00 1999
Path: biosci!biosci!not-for-mail
From: Judah Boulet <jboulet@cellbio.emory.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: bacteriorhodopsin
Date: 7 Apr 1999 08:22:18 -0700
Organization: Emory University
Lines: 5
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <7eft7a$pij@net.bio.net>
Reply-To: jboulet@cellbio.emory.edu
NNTP-Posting-Host: net.bio.net

I am trying to get some feedback on a ongoing debate.  The question
revolves around the use of bacteriorhodopsin as a relevant model for all
G-protein linked receptors.  I believe it is a good model to use to get
better understanding of structure/function relationships.  ANy feedback
would be great!

From owner-7tms_r@net.bio.net Mon Apr 19 23:00:00 1999
Path: biosci!biosci!not-for-mail
From: RNeubig@umich.edu (Rick Neubig)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Mol Pharm BBS Journal Club
Date: 20 Apr 1999 08:05:57 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 15
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <7fi54l$ij9@net.bio.net>
NNTP-Posting-Host: net.bio.net


Hello 7tms'rs,
Check out the Journal Club by Bryan Roth on the ASPET Division for Molecular
Pharmacology Bulletin Board at http://swift.med.umich.edu/~MolPharm

RNA EDITING OF THE HUMAN 5-HT2C RECEPTOR SILENCES CONSTITUTIVE ACTIVITY
Niswender, Copeland, Herrick-Davis, Emeson and Sanders-Bush
JBC 274: 9472-9478-1999

Rick

P.S. If you want to get the Journal Club postings by e-mail log on to the
BBS through the web address above then click More/Mailing Lists and click
the checkbox for Journal Club and any other mail lists to which you'd like
to subscribe.

From owner-7tms_r@net.bio.net Mon Apr 19 23:00:00 1999
Path: biosci!biosci!not-for-mail
From: Joan Boyce <boyce@cshl.org>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: 1999 Source Book Available Free to Researchers
Date: 20 Apr 1999 14:00:34 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 17
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <7fipti$ai7@net.bio.net>
Reply-To: boyce@cshl.org
NNTP-Posting-Host: net.bio.net

Obtain a free copy of the 1999 Source Book, a comprehensive guide to
bioresearch products, by filling in the request form at the BioSupplyNet
site: http://www.biosupplynet.com. The Source Book provides up-to-date
information about reagents, lab instrumentation, antibodies, custom
services and supplies. 

Biomedical researchers will find that the unique organization of the
Source Book simplifies product searching and speeds the gathering of
comparative information. The Source Book indexes products in 2650
categories, and provides up-to-date contact information, including WWW
and e-mail addresses, for 3500 suppliers. Bench Basics comparative
tables allow apples-to-apples comparisons of products. A special Lab
Set-up Check List simplifies the process of putting together a new
laboratory.

Order your free copy at The BioSupplyNet web site at
http://www.biosupplynet.com

From owner-7tms_r@net.bio.net Mon Apr 19 23:00:00 1999
Path: biosci!biosci!not-for-mail
From: roth@biocserver.BIOC.CWRU.Edu
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: position available
Date: 20 Apr 1999 08:04:16 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 27
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <7fi51g$i5s@net.bio.net>
NNTP-Posting-Host: net.bio.net

A position is available immediately for an individual interested in high
through-put screening of GPCR's and transporters.  The individual will
perform binding and functional assays for a variety of GPCR's, transporters
and channels as part of the NIMH Psychoactive Drug Screening Program (see
URL below).  Experience with radioligand binding and functional assays
required.

For information, contact me via email and/or phone.


Bryan Roth MD, PhD
Departments of Psychiatry, Biochemistry and Neurosciences
Room W438, Department of Biochemistry
10900 Euclid Avenue
Cleveland, OH 44106-4936

216-368-2730 (Office)
216-368-3419 (Fax)
roth@biocserver.cwru.edu

For information about the NIMH Drug Screening Program view web site at:

http://meds20785.cwru.edu/myweb/newpage13.htm

Roth lab home page at:

http://meds20785.cwru.edu/rothlab/

From owner-7tms_r@net.bio.net Mon Apr 19 23:00:00 1999
Path: biosci!biosci!not-for-mail
From: BIOSCI Administrator <biohelp@net.bio.net>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: BIOSCI/bionet miniFAQ & Fundraiser
Date: 20 Apr 1999 08:05:04 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 232
Sender: daemon@net.bio.net
Approved: lfk@gcrdb.uthscsa.edu
Distribution: world
Message-ID: <7fi530$iga@net.bio.net>
NNTP-Posting-Host: net.bio.net

(LAST REVISION: 30-JUL-95)

This BIOSCI "miniFAQ" is designed to answer the questions that come up
the *most frequently*.  The main BIOSCI FAQ (Frequently Asked
Questions) is accessible on the World Wide Web at URL
http://www.bio.net/.

If you can not find an answer to your question in this or other
documentation, the BIOSCI technical support staff answers e-mail
queries sent to

		       biosci-help@net.bio.net

We can only answer questions about the use of the newsgroups and
mailing lists.  We unfortunately do not have the staff to do Internet
information searches or answer scientific questions.  Please post
those to the appropriate BIOSCI/bionet newsgroups.


	Contents:
	--------
	0) BIOSCI NEEDS YOUR SUPPORT!!

	1) Using the WWW to access the BIOSCI/bionet newsgroups.

	2) What to do about "spams," i.e., junk mail, ads, etc.

	3) Examples of subscribing and unsubscribing to the mailing lists.

	4) The BIOSCI user address and research interest directory.


0) BIOSCI NEEDS YOUR SUPPORT!!
- ------------------------------
BIOSCI's government funding has been expended, and we are now
operating solely from advertising revenue that we have raised from our
Web site at http://www.bio.net/.  We need just a few minutes of your
time to help us serve you.

You can do two important things which will take very little time for
you individually and will immensely help us continue to help you.

First, please use our WWW system at http://www.bio.net/ to access the
archives.  You can post or reply to messages via your Web browser as
described in item #1 below.  Your usage helps attract sponsors. If you
contact any of our sponsors, please be sure to thank them for
supporting BIOSCI. It is critical for them to get this feedback if
they are to continue their sponsorship for the long term.

Second, if you work for a company or organization that provides
products or services of interest to the biology community, please pass
this message on to your marketing or marketing communications
department or other appropriate group.  Please ask them to help
support BIOSCI by sponsoring our Web site and explain the uses and
benefits of the system to the biology community. If they are
interested, they can then contact us for further information at our
tech support address, biosci-help@net.bio.net.


1) Using the WWW to access the BIOSCI/bionet newsgroups.
- --------------------------------------------------------
As of 10 December 1995, all BIOSCI/bionet full newsgroups are
accessible through the World Wide Web (WWW) at URL http://www.bio.net.
One can read and reply publicly or privately to both recent postings
and archived messages through one's Web browser if it is configured
properly to send e-mail.  Each newsgroup is equipped with its own WAIS
index.  The main BIOSCI home page also has access to the BIO-JOURNALS
Table of Contents database WAIS index and the BIOSCI user address
database described in another item further below.


2) What to do about "spams," i.e., junk mail, ads, etc.
- -------------------------------------------------------
BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups),
mailing lists, and a hypermail archive at URL http://www.bio.net/.
The same postings are distributed on all media (except for a small
number of mailing-list-only groups at net.bio.net).  Unfortunately it
is becoming a despicable practice on the Internet (by a few people out
to make a fast buck) to do automated mass postings to thousands of
newsgroups and mailing lists.  These attempts to grab free advertising
are refered to as "spams" in the usual, somewhat boneheaded, net
terminology.  USENET is more susceptible to this practice, and many
spams originate on the USENET groups and then are passed on to the
mailing lists.  However, spammers also get lists of mailing addresses
and hit these too, so neither medium is immune.

What should you do personally if you get junk mail?
- ---------------------------------------------------
Just delete it and move on without reading it further.  Filing a
protest is becoming increasingly useless because spammers are often
disguising the addresses where the messages are sent from.  Unless you
really understand Internet mail systems, your attempt at protest by
sending replies to the message will often end up being sent to the
address of an innocent person that the spammer is victimizing.

What can BIOSCI/bionet do to protect its newsgroups?
- ----------------------------------------------------
The only solution currently available is to moderate the newsgroup.
If this newsgroup is already moderated, then you are in good shape.
Moderation protects the USENET distribution from about 95% of the
spams that are being sent to date and protects the mailing lists
completely.  Moderation means, however, that someone has to take the
time to review each message before it goes out.  We have set up
software here that simply allows the moderator to forward to an
address at net.bio.net messages that (s)he wishes to have distributed.
This takes no more time than that needed to read the message and pass
it on, say about 1 min. per message.

Most newsgroups currently have a discussion leader who is responsible
for their newsgroup.  The discussions leaders and their e-mail
addresses are listed in the BIOSCI Information Sheet which is
available on the Web at http://www.bio.net/.  If a newsgroup is being
hit with too many junk postings, please contact the discussion leader
for that group and see if there is interest in moderating the group.
Please do not assume that by simply posting a complaint to the
newsgroup itself, anyone on the BIOSCI staff will act on your
complaint.  With close to 100 newsgroups to run, the BIOSCI staff has
to rely on the discussion leaders of each newsgroup to report problems
directly to us at biosci-help@net.bio.net.

We will moderate any of our newsgroups if the discussion leader tells
us that the readership of the group wishes to do so and if a moderator
is willing to do the work.  For most BIOSCI/bionet groups, this
entails only a few minutes of work each day.

Moderating a newsgroup will resolve probably 95% of the junk postings
on the USENET distribution.  Unfortunately there are easy ways for
determined spammers to override the moderation mechanism on USENET,
but we can protect our e-mail subscribers from unwanted postings if
the newsgroup is moderated.  You can also access our newsgroups over
the WWW at URL http://www.bio.net.  While this Web interface will not
stop spammers from trying to post to the groups, this will give you
yet another way, besides using USENET news, to keep the junk out of
your personal mail files.  For those of you with local USENET news
systems, the Web interface will also give you faster access to new
newsgroups and recent postings.


3) Examples of subscribing and unsubscribing to the mailing lists.
- ------------------------------------------------------------------
PLEASE NOTE: The BIOSCI management does NOT act on
subscription/unsubscription requests that are posted improperly to the
newsgroups and mailing lists.  People who do this only bother everyone
on the lists to no avail.  Please be sure to follow the proper
procedures below.

Gory details are in the BIOSCI Information sheets on the Web at
http://www.bio.net.  Below we give an example utilizing the
METHODS-AND-REAGENTS list at both of our two BIOSCI sites:

Users in the Americas and Pacific Rim countries who use the BIOSCI
- ------------------------------------------------------------------
node at computer net.bio.net:
- ----------------------------

A) Determine the "listname" which is the <=8 character mail address
                                         ^^^^^^^^^^^^^
   for the group.  These can be found in the BIOSCI Info. Sheet.  For
   the METHODS-AND-REAGENTS group the mailing address is
   methods@net.bio.net.  The listname is the portion of the address to
   the left of the @ sign, i.e., "methods".  The listname is used with
   the "subscribe" and "unsubscribe" commands illustrated below.

B) Mail all commands in the body of a mail message addressed to
   biosci-server@net.bio.net.  Do NOT send commands to the newsgroup
   posting addresses!  Leave the Subject: line blank, any text on it
   will be ignored.

C) In the body of your message put one or more of the following
   commands with an "end" command on the last line, e.g.,

   subscribe methods
   unsubscribe methods
   end

   Do NOT put your e-mail address or other text on these lines.  The
   server only allows you to cancel your subscription if the address
   on your mail header matches the address on our mailing list.
   Please ask for help at biosci-help@net.bio.net if your address has
   changed, e.g., if you know you are on the list but the server tells
   you that you are not a member.


Users in Europe, Africa, and Central Asia who use the BIOSCI node at
- --------------------------------------------------------------------
computer daresbury.ac.uk (also known as dl.ac.uk):
- -------------------------------------------------

To subscribe and unsubscribe to/from the BIOSCI lists, you need to
specify the full USENET newsgroup name with "bionet-news." prepended.
The USENET newsgroup names are listed in the BIOSCI Information sheet
on the Web at http://www.bio.net/.  For the METHODS-AND-REAGENTS list
the USENET newsgroup name is bionet.molbio.methds-reagnts, thus the
appropriate commands are

    sub bionet-news.bionet.molbio.methds-reagnts

    unsub bionet-news.bionet.molbio.methds-reagnts

These commands are included in a message addressed to mxt@dl.ac.uk,
NOT to the newsgroup mailing addresses.  As usual, include the text in
the body of the message as text on the Subject: line is ignored.

To unsubscribe from all the lists at the UK node, use

    unsub bionet-news

Please note that if the address in the list is different than the one
in your mail message header, you will not be able to unsubscribe by
this method. If you have problems, please mail biosci@daresbury.ac.uk.


4) The BIOSCI user address and research interest directory.
- -----------------------------------------------------------
Please take this opportunity to add your name, address, and research
interest information to the BIOSCI User Address Database if you have
not already done so.

You can fill out the address form directly through our Web page at URL
http://www.bio.net/adrform.html.

The address database is reindexed nightly for WWW access (the URL is
http://www.bio.net/).  If you are not directly on the Internet but can
reach it by e-mail, please use our waismail server to access the user
directory.  waismail use is described above.  You can also request a
user address form by e-mail from biosci-help@net.bio.net.

Please check your database entry from time-to-time to see if your
address information is still up-to-date.  Because of our limited
personnel resources, we ask that you resubmit a *complete* form to
revise your entry; we only replace complete entries and do not have
resources to edit old forms.

